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Brief summary: Blood cultures were positive in 9 of 845 sequentially studied Vietnamese 
adults with severe falciparum malaria. In contrast to children, concomitant bacteremia in 
adults with severe malaria is uncommon, and does not warrant use of empirical antibiotics 
in all patients. 
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Abstract 
Background: Approximately 6% of children hospitalised with severe falciparum malaria in 
Africa are also bacteremic. It is therefore recommended that all children with severe malaria 
should receive broad spectrum antibiotics in addition to parenteral artesunate. Empirical 
antibiotics are not recommended currently for adults with severe malaria.  
Methods: Blood cultures were performed on sequential prospectively studied adult patients 
with strictly defined severe falciparum malaria admitted to a single referral centre in 
Vietnam between 1991 and 2003. 
Results: In 845 Vietnamese adults with severe falciparum malaria admission blood cultures 
were positive in 9 (1.07%: 95%CI 0.37 to 1.76%); S. aureus 2, S. pyogenes 1, S. Typhi 3, Non-
typhoid Salmonella 1, K. pneumoniae 1, H. influenzae type b 1. Bacteremic patients 
presented usually with a combination of jaundice, acute renal failure and high malaria 
parasitemia. Four bacteremic patients died compared with 108 (12.9%) of 836 non-
bacteremic severe malaria patients; risk ratio 3.44 (95%CI 1.62 to 7.29). In patients with 
>20% parasitemia the prevalence of concomitant bacteremia was 5.2% (4/76: 95%CI 0.2 to 
10.3%) compared with 0.65% (5/769: 0.08 to 1.2%) in patients with <20% parasitemia, a risk 
ratio of 8.1 (2.2 to 29.5). 
Conclusions: In contrast to children, the prevalence of concomitant bacteremia in adults 
with severe malaria is low. Administration of empirical antibiotics, in addition to artesunate, 
is warranted in the small subgroup of patients with very high parasitemias, emphasising the 
importance of quantitative blood smear microscopy assessment, but it is not indicated in 
the majority of adults with severe falciparum malaria. 
Keywords: Plasmodium falciparum, malaria, severe malaria, bacteremia  
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Introduction 
Malaria is associated with bacterial infection but the relationship is complex (1). In endemic 
areas, where the majority of symptomatic malaria occurs in children (i.e. areas of moderate 
or high transmission), malaria is associated with an increased risk of bacteremia (2-9). This 
risk is greatest in severe falciparum malaria. In a meta-analysis of 7,208 children with 
severe malaria, included in 25 studies across 11 African countries, the mean prevalence of 
invasive bacterial infections was estimated to be 6.4% (95% confidence interval 5.81 to 
6.98%) (8).  In these malaria endemic areas it is now generally accepted that children 
presenting with severe malaria should receive broad spectrum antibiotics in addition to 
parenteral artesunate (1, 10), as concomitant bacteremia cannot be excluded, and it is 
difficult to distinguish clinically between severe malaria and sepsis (11, 12). A severely ill 
febrile child with a low parasitemia could have severe malaria, or sepsis with incidental 
parasitemia. In contrast in prospective studies of severe malaria conducted in low 
transmission settings, where the majority of patients are adults, concomitant malaria and 
sepsis have been reported rarely – although there are few incidence data (13,14). Currently 
empirical antibiotic treatment is not recommended in adults with severe malaria (1, 10). 
However, two recent overlapping studies from Myanmar have challenged this 
recommendation. These studies found that 13 of 87 (15%) adult patients hospitalised with a 
diagnosis of malaria were bacteremic (i.e. a substantially higher proportion than in African 
children with severe malaria) (15, 16). Their report concluded that “clinicians should have a 
lower threshold for commencing empirical antibacterial therapy in adults diagnosed with 
falciparum malaria in these locations than is presently recommended”.  Clearly this is an 
important issue. We report a very large prospectively studied series of Vietnamese adults 
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with strictly defined severe falciparum malaria in whom blood cultures were taken routinely 
in all patients on admission to the specialist treatment ward. 
 
 
Methods 
This investigation took place in the severe malaria ward of the Hospital for Tropical Diseases, Ho Chi 
Minh City, Vietnam during two sequential studies of adult patients admitted with strictly defined 
severe falciparum malaria. The first, conducted between 1991 and 1996, was a double-blind 
comparison of intramuscular quinine and intramuscular artemether (17), and the second, conducted 
between 1996 and 2003, was a double-blind comparison of intramuscular artesunate and 
intramuscular artemether (18). These two studies, reported previously in detail, were contiguous 
and all eligible patients were enrolled. Both studies were approved by the Ethical and Scientific 
Committee of the Hospital for Tropical Diseases, Ho Chi Minh City. 
Entry criteria 
Patients were included in the studies if they (or an accompanying relative) gave informed 
consent, they had asexual forms of P. falciparum on a peripheral-blood smear, were older 
than 14 years, were not in the first trimester of pregnancy, were not intravenous drug users, 
had received less than 3g of quinine or two doses of artemisinin or a derivative in the 
previous 48 hours, were not allergic to the study drugs, and had one or more of: Glasgow 
Coma Scale score <11 (indicating cerebral malaria); anemia  (hematocrit, <20%) with a 
parasite density >100,000/uL; jaundice (serum total bilirubin, >2.5 mg/dL [50 µmol/L]) with a 
parasite density >100,000/uL; acute kidney injury (urine output, <400 ml/24 hours and 
serum creatinine, >3 mg/dL [250 µmol/L]); hypoglycemia (blood glucose, <40 mg/dL [2.2 
mmol/L]); >10% parasitemia; and systolic blood pressure <80 mm Hg with cool extremities 
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(indicating shock). These criteria are similar to the WHO endorsed definition (1) except that 
the anemia criterion is more stringent. 
Clinical Management and Procedures  
On enrolment patients were examined, weighed, and baseline blood samples were taken for full 
blood count, clotting studies, biochemistry, arterial pH and blood gases, blood cultures and thin and 
thick film malaria parasite counts. A full history was taken from the patient or attendant relatives 
and a full clinical examination performed including a detailed neurologic assessment. A urinary 
catheter was inserted. Patients were managed by a dedicated team according to standard 
recommendations (1). Antimalarial treatment was started immediately with either artesunate, 
artemether or quinine according to randomization as described previously (17, 18). All patients were 
given isotonic saline initially, and fluid balance was then maintained with 0.9% saline or 5% dextrose 
in water. When necessary, a central venous catheter was inserted and the central venous pressure 
maintained at 5 cm of water. Blood was transfused if the hematocrit fell below 20%. Hypoglycemia 
was corrected with injection of 50 ml of 30% dextrose and a subsequent maintenance infusion of 5% 
to 10% dextrose in water. Detailed clinical and nursing observations were recorded a minimum of 
every 4 hours for the first 24 hours. A diagnostic lumbar puncture was performed if the Glasgow 
Coma Scale score was below 14.  Hemofiltration was started in patients with established renal 
failure. Patients with respiratory failure were ventilated. Acetaminophen was given for high fever 
(>39°C), and intravenous diazepam, intramuscular phenobarbital, and if necessary, intravenous 
phenytoin were given for convulsions. Antibiotics with no clinical antimalarial activity (i.e., usually 
cefotaxime 2mg/kg 6 hourly or ceftriaxone 2g daily but not tetracyclines, macrolides, trimethoprim–
sulfamethoxazole, or chloramphenicol) were given only if indicated clinically or cultures were 
positive, and confirmed enteric fever was treated with ofloxacin, but antibiotics were not started 
routinely.  
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Microbiology 
Between 5 and 15 mL blood was taken for blood cultures (target 10mL). Between 1991 
and 1997 a manual blood culture system was used (18). Each 5mL venous blood aliquot 
was inoculated into 50mL of brain heart infusion broth (Tissue Culture Services, UK) with 
0.05% sodium polyanethol sulfonate (Sigma, St Louis, MO, USA). Blood culture bottles were 
vented and incubated at 35-37oC for 7 days. Blind sub-culture was performed at 24 and 48 h 
and at 7 days or whenever physical growth was observed in the bottles. In September 1997 
a BACTEC® culture system was introduced. Aliquots of blood (5 to 8mL) were inoculated into 
BACTEC plus aerobic bottles (Becton-Dickenson, USA) and then incubated for five days in a 
BACTEC 9050® automated analyser. Bottles that gave a positive signal were sub-cultured. 
Sub-cultures were onto fresh sheep blood agar, and heated blood (chocolate) agar if 
Haemophilus influenzae or Neisseria meningitidis was suspected, and onto Sabouraud’s agar 
if a yeast or mould was suspected (all media supplied by Oxoid Unipath, Basingstoke, UK). 
Plates were incubated at 37oC in air (blood agar) or 5% CO2 (chocolate agar) for 48 h or 30
oC 
in air (Sabouraud’s agar) for 5 days. Organisms were identified by standard methods 
including API® identification kits (Bio-Mérieux, Basingstoke, UK) when necessary. Specific 
antisera were used to identify Salmonella serogroups, including Vi for Salmonella enterica 
serovar Typhi (S. Typhi).  Staphylococcus epidermidis or other skin commensals were 
considered contaminants. 
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Statistical methods 
Proportions were compared using Fisher’s exact test using Epiinfo®.  
Results 
Blood culture results were available for 845 adult patients admitted with severe falciparum 
malaria. Of these nine were positive for pathogens, a prevalence of 1.07% (95%CI 0.37 to 
1.76%). The organisms cultured were Salmonella Typhi (3), non-typhoid Salmonella (1), 
Staphylococcus aureus (2), Group A streptococcus (1), Haemophilus influenzae type b (1) and 
Klebsiella pneumoniae (1) (Table 1). An additional patient’s blood grew B. cepacia but this 
was regarded as a contaminant, and the patient recovered uneventfully without receiving 
antibacterial treatment. The usual clinical presentation in these bacteremic patients was 
with the hepatorenal syndrome of fever, jaundice and acute kidney injury accompanied by 
high parasitemia. One patient was unconscious (cerebral malaria).  
Fatal cases 
Four of the nine patients with severe malaria and concomitant bacteremia died; 
1. A 47 year old male farmer admitted with 20.1% parasitemia, jaundice and shock died 
2.5 hours after admission.  Blood cultures subsequently grew Staphylococcus aureus. 
2. A 24 year old male farmer with a seven day history of fever had generalized 
convulsions followed by coma on the day of admission. His parasitemia was 0.9%. He had 
clinical signs of pneumonia, for which he was given ceftriaxone but he died 29 hours later 
without regaining consciousness. Blood cultures subsequently grew Salmonella Typhi. 
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3. A 28 year old male soldier with a five day history of fever was admitted with 24.9% 
parasitemia, jaundice and acute renal failure. He died 16 hours later. Blood cultures 
subsequently grew Haemophilus influenzae type b. 
4. A 48 year old male builder with a six day history of fever presented with 24.6% 
parasitemia, hyperlactatemia, acute oliguric kidney injury, jaundice, pulmonary edema and 
upper gastrointestinal bleeding. Hemofiltration was started immediately. His parasitemia 
rose to 54% within 8 hours of admission. He received artemether and, because sepsis was 
suspected clinically, he was given ceftriaxone. On day 2 blood cultures grew Klebsiella 
pneumoniae, and amikacin was added. After a protracted course he developed nosocomial 
pneumonia and he died 24 days later.  
The overall mortality of patients with severe malaria but no concomitant bacteremia was 
significantly lower; 12.9% (108/836). The risk ratio for death in patients with concomitant 
bacteremia was 3.44 (95%CI 1.62 to 7.29), p=0.022.  
Risk factors 
The nine patients admitted with severe malaria and concomitant bacteremia were slightly 
older (median 47 years, range 17 to 60 years) than the other 836 patients (median 31 years, 
range 15 to 79 years).  They were also more likely to be hyperparasitemic; the median 
(range) parasite count was 501,144/uL (39,564 to 1,765,936/uL) compared to 81,766/uL 
(12,811 to 316,512)/uL in the non-bacteremic severe malaria patients. Four of the 9 
bacteremic patients had >20% parasitemia compared with 72 of 836 non-bacteremic 
patients; risk ratio 5.16 (95%CI 2.41 to 11.07); p =0.0054. Thus the prevalence of 
concomitant bacteremia in patients with >20% parasitemia was 5.2% (4/76:  95%CI 0.2 to 
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10.3%) compared with 0.65% (5/769: 0.08 to 1.2%) in patients with <20% parasitemia, a risk 
ratio of 8.1 (95%CI 2.2 to 29.5). Mortality in non-bacteremic patients with >20% parasitemia 
was 18% (13 of 72). Leukocytosis, which may also occur in very severe malaria infections, 
and other hematological or biochemical indices were not useful as indicators of concomitant 
bacteremia. Only one of the eight bacteremic patients with a differential white count 
performed on admission had a neutrophilia.  
Community acquired bacteremias 
Between 1991 and 2000, during which 90% of the patients in this series were recruited, 
Salmonella Typhi was the predominant pathogen recovered from blood cultures taken in 
the hospital (18) comprising 41% (91/219) of isolates in 1991 and 25% (85/334) in 2000. 
Corresponding proportions for Staphylococcus aureus were 14% (31/219) in 1991 and 10% 
(33/334) in 2000. 
Discussion 
In this large prospective study of Vietnamese adults admitted to hospital with strictly 
defined severe falciparum malaria the rate of concomitant bacteremia was low. This 
contrasts with large studies in African children with severe malaria in whom concomitant 
bacteremia is sufficiently common (more than five times more common than in adults in 
this series) (8), and the clinical distinction between severe malaria and sepsis is sufficiently 
difficult (11, 12) to warrant administration of antibiotics on admission to all children with a 
diagnosis of severe malaria (1, 10). This low rate of concomitant bacteremia in adults 
supports current recommendations that empiric antibiotics should not be given on 
admission to adults with severe malaria, unless there is clear evidence of a bacterial 
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infection (1, 10). The important exception is patients with very high parasite densities (>20% 
parasitemia) who were 5.2 (95% CI 2.4 to 11.1) times more likely to be bacteremic. These 
high parasite counts in bacteremic patients, particularly the fatal cases, suggest that disease 
severity resulted primarily from malaria illness. The increased risk of bacteremia with very 
high parasitemias may reflect more intense parasitized sequestration (e.g. in the gut) and 
vital organ dysfunction (1) or more specifically host-phagocytic dysfunction resulting from 
the massive intravascular release of parasite cellular components and malaria pigment. 
Salmonella infections (particularly non-typhoid Salmonella) have been associated 
specifically with falciparum malaria infections in African children (2, 3, 5, 8, 20). In this study 
one third of the bacteremias were with Salmonella Typhi and it is noteworthy that S. Typhi 
was also the most common cause of community acquired bacteremia identified in Ho Chi 
Minh City during this period (19, 21). Although empirical antibiotics are not indicated on 
admission in adults with severe malaria unless they have very high parasite counts, 
antibiotic treatment may well be needed subsequently in patients who deteriorate (1), as 
nosocomial bacterial infections are relatively common following admission in severely ill 
patients.  
These results contrast markedly with a recent study from Myanmar in which 15% (13 of 87) 
of adults hospitalised with a primary diagnosis of malaria were bacteremic (16). Malaria transmission 
in both countries is generally low and seasonal. However the Myanmar patient characteristics were 
very different to those of the Vietnamese adults with strictly defined severe falciparum malaria. Only 
some of the Myanmar patients may have had severe malaria, semi-quantitative malaria parasite 
counts were generally low (and were significantly lower in bacteremic than non-bacteremic 
patients), and many had neutrophil leucocytosis, all suggesting a primarily bacterial illness. The 
prevalence of bacteremia in the Myanmar adult patients was 23 times higher than in the Vietnamese 
adults with strictly defined severe falciparum malaria and <20% parasitemia (15% versus 0.65%). 
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/article-abstract/doi/10.1093/cid/ciaa191/5763096 by Liverpool School of Tropical M
edicine user on 16 April 2020
 12 
 
Even in the three Myanmar fatal cases parasite counts were low (recorded as 1+ in two, and 2+ in 
one), whereas all the parasite counts of the Vietnam bacteremic patients would have scored 4+ in 
the semi-quantitative system - and with quantitative counts four had >20% parasitemia (of whom 3 
died). The low overall mortality in the Myanmar series 3.4% (3/87) was attributed to early use of 
antibiotics, yet most of the Vietnamese patients did not receive antibiotics. It is therefore very 
unlikely that a high proportion of them had covert bacterial septicemia. The simplest and most 
probable explanation for the marked difference between the two studies relates to the primary 
diagnosis. The Vietnam patients undoubtedly had severe falciparum malaria as their primary 
condition, with bacteremia  occurring late in the course of their illness, whereas it is likely that the 
bacteremic Myanmar patients had bacterial sepsis as their primary condition, and their malaria 
parasitemia was incidental (i.e. their fever and illness were caused by their bacterial infections and 
not malaria). This would explain the apparent high prevalence of bacteremia, their very low parasite 
counts and their neutrophil leukocytosis. Asymptomatic parasitemias are common in malaria 
endemic areas. It is understandable that an ill febrile patient with a positive malaria smear would be 
considered to have malaria if there was no obvious focus of bacterial infection. However severe 
falciparum malaria results from a current or previous large sequestered parasite burden (1), whereas 
incidental parasitemia is associated with parasite burdens which are many orders of magnitude 
lower (22). These two very different syndromes, requiring different management, can be 
distinguished by quantitative malaria parasite counts and by other parasite burden indicators such 
as the proportions of neutrophils containing malaria pigment, the stage of malaria parasite 
development, and plasma concentrations of PfHRP2 or P. falciparum DNA (23-26).  As parasite 
counting, staging and neutrophil pigment assessment can all be done rapidly on admission thin and 
thick film blood films, this emphasises the value of experienced microscopy in the assessment of 
patients hospitalised with malaria. From taking the blood smear to completing the thin-film parasite 
count can take as little as five minutes (27). Semi-quantitative counts using the old “plus” or “cross “ 
system are unreliable and are no longer recommended by the World Health Organisation (28). They 
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are particularly unsuited for patients hospitalised with malaria as the maximum semi-quantitative 
count of 4+ (>10 parasites in one thick blood film oil-immersion high power field) encompasses 
parasitemias ranging from <1% to 100%. Misdiagnosis also contributes significantly to the high rates 
of concomitant bacteremia and “severe” malaria reported in African children (25), and explains 
many of the apparent associations between both falciparum and vivax malaria and a variety of 
unrelated conditions. The high prevalence of asymptomatic parasitemia in endemic areas means 
that many patients admitted to hospital with other conditions will be labelled as having malaria. In a 
retrospective review of 400 adult patients with severe imported malaria admitted to 45 French 
intensive care units 9 (2.3%) were bacteremic and one had candidemia on admission (29). However 
the patients in France were substantially older (median age 45 years) than the Vietnamese adults in 
this series, 7.3% of patients had immune deficiencies, and 14.3% had one or more co-morbidities. 
Although this study in Vietnamese adults was long, large and detailed, it has several 
limitations. Empirical use of antibiotics before admission to hospital is common in Asia (and was 
reported in 35% of the Myanmar series) and could have obscured some bacterial infections. 
However, prior antibiotic use was unusual in the low-income rural population at risk from malaria in 
Vietnam between 1991 and 2003, so is unlikely to be a significant confounder. Blood culture is 
intrinsically insensitive so bacteremia was probably underestimated. The target blood volume 
cultured (10mL), which was the same in both the Myanmar and Vietnam series, is not maximally 
sensitive (30, 31). It is also noteworthy that 6 of the 9 positive blood cultures were obtained 
following change to the automated blood culture system, so the earlier manual culture system may 
have been less sensitive.  However, the Vietnamese patients with severe malaria were not given 
routine antibiotics after admission, yet 87% survived, and most deaths were clearly attributable to 
severe falciparum malaria. It seems very unlikely that these various differences could account for the 
marked discrepancy between this and the Myanmar series, particularly as many of the Myanmar 
patients did not have strictly defined severe malaria. 
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High parasitemia was clearly a risk factor for concomitant bacteremia. Of the 76 
patients with >20% parasitemia (9% of the total), 4 (5.2%) were also bacteremic. This group 
has a high mortality, so giving broad spectrum antibiotics empirically to patients with very 
high parasitemias is justified. Thin blood smear assessment should be performed on all 
patients admitted with severe falciparum malaria. Overall however, in contrast to children 
in areas of higher malaria transmission, the incidence of concomitant bacteremia in adults 
with severe malaria is low and does not warrant use of empirical antibiotics in all patients. 
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Table 1: Clinical and laboratory features on admission of Vietnamese adults with severe falciparum malaria and concomitant bacteremia .  
 Age/ 
sex 
Weigh
t 
(kg) 
Days 
of 
feve
r 
GC
S 
T 
(
o
C) 
Antimalaria
l 
drug 
Antibiotic Parasite 
count/ 
µL 
Parasitemi
a 
(%) 
PC
V 
(%) 
White 
blood 
count
/ µL 
(%N) 
Plasma 
Creatinin
e 
(mg/dL) 
Total 
Bilirubi
n 
(mg/dL) 
Plasma 
lactate 
(mmol/L
) 
Organism 
isolated 
Outcom
e 
1 47M 45 3 14 37 Quinine none 1,161,29
8 
20.1 
 
 
46 - 5.6 - 5.9 S. aureus Died 
2 24M 54 
7 
15 38.
3 
Artemether Ofloxacin 224,322 4.7 
 
38 7,800 
(74) 
2.6 2.4 - S. Typhi Survived 
3 17F 39 
4 
15 38.
2 
Artemether Ofloxacin 501,144 11.4 
 
35 4,300 
(67) 
8.5 3.6 3.8 S. Typhi Survived 
4 24M 
 
65 
15 
4 38.
5 Artemether Ceftriaxone 39,564 
0.9 
 35 
9,210 
(60) 1 1.7 - 
S. Typhi Died 
5 60M 
 
54 
5 
15 37.
0 Artemether Ofloxacin 128,740 
4.1 
 25 
3,500 
(75) 8.6 0.92 0.8 
NTS Survived 
6 57M 
 
60 
6 
14 37.
5 Artesunate 
Ceftriaxone 
+ Oxacillin 38,685 
0.7 
44 
8,400 
(79) 2.1 9.8 1.5 
S. aureus Survived 
7 25M 
 
50 
3 
12 37.
5 Artemether none 906,958 
24.9 
29 
14,850 
(54) 5.6 - 7.0 
H. 
influenzae B 
Died 
8 48M 
 
 
76 6 14 38.
0 
Artemether 
Ceftriaxone
+ Amikacin 
1,235,90
4 
24.6 
40 
6,860 
(53) 3.1 8.7 11.6 
K. 
pneumonia
e 
Died 
T (oC): temperature, (%N): % neutrophils, PCV: hematocrit, NTS: non-typhoid Salmonella.  
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